亚洲AV成人片色在线观看高潮_亚洲精品成a人在线观看夫_日本久久久久久久久精品_亚洲精品无码成人在线观看

羧肽酶N1(CPN1)多克隆抗體

Polyclonal Antibody to Carboxypeptidase N1 (CPN1)

CPN; SCPN; ACBP; Anaphylatoxin inactivator; Arginine carboxypeptidase; Kininase-1; Lysine carboxypeptidase; Plasma carboxypeptidase B; Serum carboxypeptidase N

  • 羧肽酶N1(CPN1)多克隆抗體 產(chǎn)品包裝(模擬)
  • 羧肽酶N1(CPN1)多克隆抗體 產(chǎn)品包裝(模擬)
  • 羧肽酶N1(CPN1)多克隆抗體 IHC圖
  • PAF323Hu01.jpg Figure. Western Blot; Sample: Recombinant CPN1, Human.
  • 羧肽酶N1(CPN1)多克隆抗體 Western Blot; Sample: A549 cell lysate; <br/>Primary Ab: 1.5μg/ml Rabbit Anti-Human CPN1 Antibody<br/>Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19) Selected
  • 羧肽酶N1(CPN1)多克隆抗體 Western Blot; Sample: Raji cell lysate; <br/>Primary Ab: 1.5μg/ml Rabbit Anti-Human CPN1 Antibody<br/>Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19) Selected
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對CPN1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別CPN1。

用法

Western blotting: 0.01-2μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號 適用物種：Homo sapiens (Human，人) 應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPF323Hu01 羧肽酶N1(CPN1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPF323Hu02 羧肽酶N1(CPN1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAF323Hu01 羧肽酶N1(CPN1)多克隆抗體 WB
PAF323Hu02 羧肽酶N1(CPN1)多克隆抗體 WB; IHC; ICC; IP.
LAF323Hu71 羧肽酶N1(CPN1)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
SEF323Hu 羧肽酶N1(CPN1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMF323Hu 羧肽酶N1(CPN1)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
PLoS One Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis [PubMed: 25789864]
Cancer Cell Int Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer [34711246]
留言咨詢